New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
07:13 EDTOXFDOxford Immunotec reports Q2 EPS (36c), consensus (20c)
Reports Q2 revenue $11.8M, consensus $11.39M.
News For OXFD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
07:00 EDTOXFDOxford Immunotec announces CE Mark approval for T-SPOT.CMV test
Oxford Immunotec Global announced that it had gained CE Marking for its T-SPOT.CMV test. The T-SPOT.CMV test leverages Oxford Immunotec's proprietary T-SPOT technology platform, and is the first in a series of planned new products intended to help transplant patients and physicians manage immune regulated conditions. The test is available now as a CE-marked kit in the EU, and will soon be available in the UK as a testing service from our UK ODL laboratory. T-SPOT.CMV is also available in the U.S. as a Laboratory Developed Test from the Company's CLIA-certified and CAP accredited ODL service laboratory.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use